GLS and cancer: We tracked tumor formation and progression in WT and GLSKO models before and after treatment with AZD0095 and found that, once lactate uptake was inhibited by AZD0095, the trajectory of tumorigenesis was diminished, specifically in tumors arising from deletion of GLS in cancer cells of origin (Fig. 7, E and F).